SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-23-008222
Filing Date
2023-12-07
Accepted
2023-12-07 21:03:12
Documents
1
Period of Report
2023-12-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 6523
  Complete submission text file 0001562180-23-008222.txt   8111
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments

Mailing Address ROOM 502-I, WANT WANT PLAZA NO. 211 SHIMEN YI ROAD SHANGHAI F4 200041
Business Address
Liu Ye (Reporting) CIK: 0001840407 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 231473789